翻訳と辞書 Words near each other ・ Eligio Cervantes ・ Eligio Echagüe ・ Eligio González Farías ・ Eligio Insfrán ・ Eligio Lofranco ・ Eligio Perucca ・ Eligio Pichardo ・ Eligio Valentino ・ Eligio Vecchi ・ Eligius ・ Eligius Fromentin ・ Eligius Pruystinck ・ Eligius Tambornino ・ Eligiusz Niewiadomski ・ Eligiów ・ Eliglustat ・ Eligma malgassica ・ Eligma narcissus ・ Eligminae ・ Eligmocarpus ・ Eligmoderma aragua ・ Eligmoderma convexicolle ・ Eligmoderma ibidionoides ・ Eligmoderma minuta ・ Eligmoderma politum ・ Eligmoderma trifasciatum ・ Eligmoderma ziczac ・ Eligmodermini ・ Eligmodontia ・ Eligmodontia typus Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Eliglustat ： ウィキペディア英語版 Eliglustat Eliglustat (INN, USAN;〔 By subscription only〕 trade name Cerdelga) is a treatment for Gaucher's disease developed by Genzyme Corp that was approved by the FDA August 2014. Commonly used as the tartrate salt, the compound is believed to work by inhibition of glucosylceramide synthase. According to an article in Journal of the American Medical Association the oral substrate reduction therapy resulted in "significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count" in untreated adults with Gaucher disease Type 1. ==Cost== In 2014, the annual cost of Cerdelga hard gelatin capsules taken orally twice a day was $310,250. Genzyme’s flagship Imiglucerase (brand name Cerezyme) cost about $300,000 for the infusions if taken twice a month. Manufacturing costs for Cerdelga are slightly lower than for Cerezyme. Genzyme's maintains higher prices for orphan drugs—most often paid for by insurers— in order to remain financially sustainable.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Eliglustat」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.